Pay in 4 interest-free payments of $7.15 Learn more
Ships within 48 hours · Estimated delivery Sep 1 - Sep 6
A planned part of the Phase 2 obesity trial looked at 98 participants who also had metabolic dysfunction-associated steatotic liver disease (MASLD, the condition formerly called non-alcoholic fatty liver disease)
Without a longer follow-up, however, its difficult to determine whether any of these lingering changes will last
Retatrutide is an investigational once-weekly subcutaneous peptide that activates GLP-1, GIP, and glucagon receptors simultaneously, aiming to suppress appetite and increase energy expenditure beyond the effect of existing approved agents
The broader literature on subcutaneous injection pharmacokinetics shows that absorption rate differences between sites are a function of tissue blood flow and fat composition
Other Ingredients: Deionized Water, Ethanol (0.648 g), Potassium Hydroxide
US$ 24.41
US$ 21.10
US$ 26.63
US$ 22.83
US$ 25.99
